UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Ulcerative Colitis and Cytomegalovirus Infection: From A to Z

Journal of Crohn's and colitis, 2020-09, Vol.14 (8), p.1162-1171

2020

Volltextzugriff (PDF)

Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study

The American journal of gastroenterology, 2024-08, Vol.119 (8), p.1536-1544

2024

Volltextzugriff (PDF)

S1183 Exclusive Enteral Nutrition Among Adult Patients With Active Crohn’s Disease: A Single Center Experience

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S905-S905

2023

Volltextzugriff (PDF)

Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats

Gastrointestinal endoscopy, 2012-04, Vol.75 (4), p.805-812

2012

Volltextzugriff (PDF)

Early thiopurine maintenance and reduced colectomy rate in ulcerative colitis: fact or fiction?

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e1106

2021

Volltextzugriff (PDF)

Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease

Journal of gastroenterology and hepatology, 2021-04, Vol.36 (4), p.990-998

2021

Volltextzugriff (PDF)

Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey

BMJ open gastroenterology, 2021-02, Vol.8 (1), p.e000581

2021

Volltextzugriff (PDF)

Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus

Gastrointestinal endoscopy, 2012-05, Vol.75 (5), p.938-944

2012

Volltextzugriff (PDF)

Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (12), p.1524

2021

Volltextzugriff (PDF)

Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia

Clinical gastroenterology and hepatology, 2015-08, Vol.13 (8), p.1453-1463.e1

2015

Volltextzugriff (PDF)

Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease

Inflammatory bowel diseases, 2017-09, Vol.23 (9), p.1555-1565

2017

Volltextzugriff (PDF)

Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease

Inflammatory bowel diseases, 2019-07, Vol.25 (8), p.1390-1398

2019

Volltextzugriff (PDF)

Determining efficacy of dynamic multimedia bowel preparation instructions versus standard instructions on adenoma detection and patient reported measures (DIGICLEAN trial): a study protocol for a multicentre, colonoscopist-blinded, randomised controlled trial

BMJ open, 2023-07, Vol.13 (7), p.e073843-e073843

2023

Volltextzugriff (PDF)

Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease

Inflammatory bowel diseases, 2014-08, Vol.20 (8), p.1382-1390

2014

Volltextzugriff (PDF)

Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study

Therapeutic advances in chronic disease, 2024-01, Vol.15, p.20406223241233203-20406223241233203

2024

Volltextzugriff (PDF)

Review of exclusive enteral therapy in adult Crohn’s disease

BMJ open gastroenterology, 2021-09, Vol.8 (1), p.e000745

2021

Volltextzugriff (PDF)

A Target 6-Thioguanine Nucleotide Level ≥ 125 is Associated with a Higher Rate and Longer Durability of Response in Infliximab-Thiopurine Combination Therapy: A Retrospective Study in Crohn's Disease Patients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S388-S388

2017

Volltextzugriff (PDF)

Medication non-adherence in inflammatory bowel diseases is associated with disability

Intestinal research, 2018, 16(4), , pp.571-578

2018

Volltextzugriff (PDF)

Mo1877 Infliximab for the Treatment of Ipilimumab (anti CTLA-4) and Nivolumab/Pembrolizumab (anti-PD-1) Associated Colitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S803-S803

2016

Volltextzugriff (PDF)

Review of therapeutic drug monitoring of infliximab in spondyloarthritis—Catching up with management concepts from other inflammatory conditions

British journal of clinical pharmacology, 2020-02, Vol.86 (2), p.194-195

2020

Volltextzugriff (PDF)

Dysplasia surveillance - a practical guide

Journal of gastroenterology and hepatology, 2016-06, Vol.31 (S1), p.31-32

Kariyawasam, Viraj

2016

Volltextzugriff (PDF)

Treatment endpoints in ulcerative colitis: Does one size fit all?

World journal of gastrointestinal pharmacology and therapeutics, 2024-05, Vol.15 (2), p.91591-91591

2024

Volltextzugriff (PDF)

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety

United European gastroenterology journal, 2017-06, Vol.5 (4), p.563-570

2017

Volltextzugriff (PDF)

343 Azathioprine Decreases the Risk of Adalimumab Primary Non-Response and Secondary Loss of Response but Only if Adequately Dosed

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-79-S-79

2014

Volltextzugriff (PDF)

Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B

World journal of gastroenterology : WJG, 2013-02, Vol.19 (5), p.721-726

2013

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(52)
Berichte
(1)

Sprache

Englisch
(53)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ulcerative Colitis and Cytomegalovirus Infection: From A to Z

Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study

S1183 Exclusive Enteral Nutrition Among Adult Patients With Active Crohn’s Disease: A Single Center Experience

Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats

Early thiopurine maintenance and reduced colectomy rate in ulcerative colitis: fact or fiction?

Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease

Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey

Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus

Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis

Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia

Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease

Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease

Determining efficacy of dynamic multimedia bowel preparation instructions versus standard instructions on adenoma detection and patient reported measures (DIGICLEAN trial): a study protocol for a multicentre, colonoscopist-blinded, randomised controlled trial

Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease

Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study

Review of exclusive enteral therapy in adult Crohn’s disease

A Target 6-Thioguanine Nucleotide Level ≥ 125 is Associated with a Higher Rate and Longer Durability of Response in Infliximab-Thiopurine Combination Therapy: A Retrospective Study in Crohn's Disease Patients

Medication non-adherence in inflammatory bowel diseases is associated with disability

Mo1877 Infliximab for the Treatment of Ipilimumab (anti CTLA-4) and Nivolumab/Pembrolizumab (anti-PD-1) Associated Colitis

Review of therapeutic drug monitoring of infliximab in spondyloarthritis—Catching up with management concepts from other inflammatory conditions

Dysplasia surveillance - a practical guide

Treatment endpoints in ulcerative colitis: Does one size fit all?

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety

343 Azathioprine Decreases the Risk of Adalimumab Primary Non-Response and Secondary Loss of Response but Only if Adequately Dosed

Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B

Suchergebnisse filtern